Bayer starts Phase III trial on regorafenib in liver cancer
FRANKFURT (Reuters) - German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug rego...
Read More »
Contact Coast to Coast AM at 1-800-825-5033
FRANKFURT (Reuters) - German drugmaker Bayer said on Wednesday it initiated a Phase III trial of its potential blockbuster drug rego...
Read More »PARIS (Reuters) - French drugmaker Sanofi SA said it and U.S. firm Regeneron Pharmaceuticals have started recruiting patients for tw...
Read More »
By Caroline Copley ZURICH (Reuters) - Swiss drugmaker Roche hopes data published this week will show it has a viable follow-on produ...
Read More »By Susan Heavey WASHINGTON (Reuters) - Americans at high risk for heart problems who have been told for years to sharply cut salt fr...
Read More »
By David Morgan WASHINGTON (Reuters) - President Barack Obama's landmark healthcare reform law will extend coverage to 2 million few...
Read More »
(Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 pe...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - The number of U.S. children who were exposed to violence, crime and abuse in 2011 wa...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Despite evidence suggesting that women whose uterus has been removed may be more lik...
Read More »RIYADH (Reuters) - Saudi Arabia has confirmed six new cases of the SARS-like novel coronavirus in its Eastern Province, state media ...
Read More »By Trevor Stokes NEW YORK (Reuters Health) - Bottling up emotions is thought to harm both mind and body, but a new study suggests th...
Read More »